The HIV Tat protein transduction domain improves the biodistribution of β-glucuronidase expressed from recombinant viral vectors
- 1 July 2001
- journal article
- research article
- Published by Springer Nature in Nature Biotechnology
- Vol. 19 (7), 640-644
- https://doi.org/10.1038/90242
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Intracranial Injection of Recombinant Adeno-associated Virus Improves Cognitive Function in a Murine Model of Mucopolysaccharidosis Type VIIMolecular Therapy, 2001
- A simple method for the rapid generation of recombinant adenovirus vectorsGene Therapy, 2000
- Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cellsNature Biotechnology, 2000
- Recombinant adeno-associated virus type 2, 4, and 5 vectors: Transduction of variant cell types and regions in the mammalian central nervous systemProceedings of the National Academy of Sciences, 2000
- Systemic Hyperosmolality Improves β-Glucuronidase Distribution and Pathology in Murine MPS VII Brain Following Intraventricular Gene TransferExperimental Neurology, 1999
- In Vivo Protein Transduction: Delivery of a Biologically Active Protein into the MouseScience, 1999
- Extensiveβ-Glucuronidase Activity in Murine Central Nervous System after Adenovirus-Mediated Gene Transfer to BrainHuman Gene Therapy, 1998
- Enzyme replacement therapy for murine mucopolysaccharidosis type VII leads to improvements in behavior and auditory function.Journal of Clinical Investigation, 1998
- Cell Internalization of the Third Helix of the Antennapedia Homeodomain Is Receptor-independentJournal of Biological Chemistry, 1996
- Tat-mediated delivery of heterologous proteins into cells.Proceedings of the National Academy of Sciences, 1994